
Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to streamline patient recruitment and trial matching, ensuring that patients receive timely and appropriate care. With over 160,000 onboarded patients and partnerships with leading pharmaceutical companies, Massive Bio is positioned as a key player in the oncology space, addressing barriers to trial enrollment and improving patient outcomes globally.

Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to streamline patient recruitment and trial matching, ensuring that patients receive timely and appropriate care. With over 160,000 onboarded patients and partnerships with leading pharmaceutical companies, Massive Bio is positioned as a key player in the oncology space, addressing barriers to trial enrollment and improving patient outcomes globally.
What they do: AI-enabled platform that matches cancer patients to clinical trials and provides real-world data and trial-activation services
Founding year: 2014/2015 (sources cite both 2014 and 2015)
Scale: Reported six-figure patient base (120k–160k+ patients) and partnerships with pharma/CROs
Recent funding: Reported total funding ≈ $23.8M; disclosed rounds include $2.6M and $9M financings
Headquarters: New York City
Clinical trial enrollment and patient-trial matching in oncology
2014
Hospitals and Health Care
2600000
Announced $2.6M financing; reported at the time to bring total funding to $6.6M
9000000
Announced $9M financing co-led by Revo Capital and Kenan Turnacioglu with participation from DEG
“Includes strategic/impact investors and development finance participants such as Revo Capital, Kenan Turnacioglu, IFC, DEG, ImpactAssets, Cavendish Impact Foundation, SiteGround Capital, and philanthropic investors”
| Company |
|---|
About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
We're recognized as a leader in health-tech innovation. Massive Bio was featured as #4 in Fast Company's Startup 100 list for Turkey and has raised $24M total funding from impact-driven investors including Revo Capital, the International Finance Corporation, and Cavendish Impact Foundation, validating both our business model and our mission-driven approach.
About The Role As the primary owner of sponsor and biopharma client relationships, you’ll play a key part in shaping customer experience and driving delivery. You’ll lead client meetings, translate asks into actionable plans, and work cross-functionally to ensure commitments are met on time and with quality. This is a sponsor-facing delivery role (not business development), success is measured by execution quality, responsiveness, and sponsor outcomes. You’ll embody best-in-class Customer Success and Account Management—where executive presence, fluent English, real-time handling of challenging questions, and thorough follow-up set the standard.
Key Responsibilities
Qualifications & Requirements
Powered by JazzHR
yRy50lLHfE